FDA Releases Revised Draft Guidance on Mixing, Diluting, or Repackaging Biological Products

Summary

The FDA has announced the availability of a revised draft guidance that outlines conditions under which the agency will not take action against pharmacies, facilities, or physicians preparing certain biological products outside the scope of approved license applications, replacing a 2015 draft guidance.